January - 2022

NEWS

Ymmunobio to Present at the Annual Meeting of the Association for Cancer Immunotherapy (CIMT)

Ymmunobio Appoints New Chief Operating Officer

Ymmunobio Accepted into Innosuisse Core Coaching

Dr. Katrin Rupalla Interviewed by Global Business Reports

Drug Discovery & Development

Fierce Biotech: Appointment of Michel Janicot

Ymmunobio AG announces appointment of Dr. Keith Skubitz

Dr. Skubitz, Professor for Hematology & Oncology, University of Minnesota, joins Ymmunobio as scientific advisor for development of...